Prothipendyl

DB12958InvestigationalSmall molecule

Prothipendyl is a neuroleptic agent indicated in the treatment of restlessness and agitation in patients with underlying psychiatric conditions. Prothipendyl has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders.

Chemical structure of Prothipendyl
Formula / weight
C16H19N3S · 285.41 g/mol (avg)
Code names
AY 56031 · D 206 · LG 206 · MH 05101

Resolves to

Compound
UNII5O6VWA87VACAS303-69-5ChEMBLCHEMBL2111030ChEBI135182PubChem14670
Clinical / RWD
RxNorm55244ATCN05AX07
Structure
InChIKeyJTTAUPUMOLRVRA-UHFFFAOYSA-NSMILESCN(C)CCCN1C2=CC=CC=C2SC2=C1N=CC=C2

What you can answer from here — as of September 17, 2026

718Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
6ContraindicationsEach with its own population and attribute set
Sign in
11Marketed productsAcross 2 countries and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 12 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Prothipendyl, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In